Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4

Nature Immunology

Volumn 6, Issue 3, 2005, Pages 280-286

  Probst, Hans Christian ^a   McCoy, Kathy ^a   Okazaki, Taku ^b   Honjo, Tasuku ^b   Van Den Broek, Maries ^a  

^a INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; PROTEIN PD 1; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; PD 1 ANTIGEN, MOUSE; PD-1 ANTIGEN, MOUSE;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CELL ACTIVATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; ANIMAL; CD8+ T LYMPHOCYTE; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; IMMUNE TOLERANCE; MICE;

EID: 14944360112     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1165     Document Type: Article

References (56)

1. Mondino, A., Khoruts, A. & Jenkins, M.K. The anatomy of T-cell activation and tolerance. Proc. Natl. Acad. Sci. USA 93, 2245-2252 (1996).
2. Derbinski, J., Schulte, A., Kyewski, B. & Klein, L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat. Immunol. 2, 1032-1039 (2001).
3. Kyewski, B., Derbinski, J., Gotter, J. & Klein, L. Promiscuous gene expression and central T-cell tolerance: more than meets the eye. Trends Immunol. 23, 364-371 (2002).
4. Bjorses, P., Aaltonen, J., Horelli-Kuitunen, N., Yaspo, M.L. & Peltonen, L. Gene defect behind APECED: a new clue to autoimmunity. Hum. Mol. Genet. 7, 1547-1553 (1998).
5. Anderson, M.S. et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 298, 1395-1401 (2002).
6. Bouneaud, C., Kourilsky, P. & Bousso, P. Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion. Immunity 13, 829-840 (2000).
7. Walker, L.S. & Abbas, A.K. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat. Rev. Immunol. 2, 11-19 (2002).
8. Steinman, R.M. et al. Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann. NY Acad. Sci. 987, 15-25 (2003).
9. Steinman, R.M., Hawiger, D. & Nussenzweig, M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685-711 (2003).
10. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531-562 (2004).
11. Tivol, E.A. et al. Loss of CTLA-4 leads to massive lymphoproliteration and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547 (1995).
12. Waterhouse, P. et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270, 985-988 (1995).
13. Perez, V.L. et al. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6, 411-417 (1997).
14. Walunas, T.L. & Bluestone, J.A. CTLA-4 regulates tolerance induction and T cell differentiation in vivo. J. Immunol. 160, 3855-3860 (1998).
15. Lindsten, T. et al. Characterization of CTLA-4 structure and expression on human T cells. J. Immunol. 151, 3489-3499 (1993).
16. Brunner, M.C. et al. CTLA-4-mediated inhibition of early events of T cell proliferation. J. Immunol. 162, 5813-5820 (1999).
17. Ishida, Y., Agata, Y., Shibahara, K. & Honjo, T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11, 3887-3895 (1992).
18. Agata, Y. et al. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 8, 765-772 (1996).
19. Nishimura, H., Nose, M., Hiai, H., Minato, N. & Honjo, T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11, 141-151 (1999).
20. Nishimura, H. et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291, 319-322 (2001).
21. Freeman, G.J. et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192, 1027-1034 (2000).
22. Latchman, Y. et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2, 261-268 (2001).
23. Okazaki, T., Iwai, Y. & Honjo, T. New regulatory co-receptors: inducible co-stimulator and PD-1. Curr. Opin. Immunol. 14, 779-782 (2002).
24. Chen, L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat. Rev. Immunol. 4, 336-347 (2004).
25. + T cell tolerance. Immunity 18, 713-720 (2003).
26. Moser, M. Dendritic cells in immunity and tolerance-do they display opposite functions? Immunity 19, 5-8 (2003).
27. Guermonprez, P., Valladeau, J., Zitvogel, L., Thery, C. & Amigorena, S. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20, 621-667 (2002).
28. Scheinecker, C., McHugh, R., Shevach, E.M. & Germain, R.N. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J. Exp. Med. 196, 1079-1090 (2002).
29. + dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J. Exp. Med. 196, 1099-1104 (2002).
30. + T cells following an acute virus infection. Eur. J. Immunol. 33, 2736-2743 (2003).
31. Probst, H.C. et al. Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression. J. Immunol. 171, 5415-5422 (2003).
32. Hou, W.S. & Van Parijs, L. A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells. Nat. Immunol. 5, 583-589 (2004).
33. + T cells. J. Exp. Med. 185, 2133-2141 (1997).
34. Robinson, S.P., Langan-Fahey, S.M., Johnson, D.A. & Jordan, V.C. Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient. Drug Metab. Dispos. 19, 36-43 (1991).
35. Krummel, M.F. & Allison, J.P. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182, 459-465 (1995).
36. + regulatory T cells in vivo in humans. Blood 100, 174-177 (2002).
37. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192, 1213-1222 (2000).
38. + regulatory T cells by targeting of antigens to immature dendritic cells. Blood 101, 4862-4869 (2003).
39. Groux, H. et al. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J. Immunol. 162, 1723-1729 (1999).
40. + T cell tolerance. J. Exp. Med. 196, 1627-1638 (2002).
41. Hawiger, D. et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194, 769-779 (2001).
42. + T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol. 172, 4676-4680 (2004).
43. Albert, M.L. Death-defying immunity: do apoptotic cells influence antigen processing and presentation? Nat. Rev. Immunol. 4, 223-231 (2004).
44. + T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J. Exp. Med. 194, 707-717 (2001).
45. Hugues, S. et al. Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic beta cells. Immunity 16, 169-181 (2002).
46. + T cells. J. Exp. Med. 186, 239-245 (1997).
47. + T cell tolerance to peripherally expressed antigens. J. Immunol. 163, 723-727 (1999).
48. + T cells. Eur. J. Immunol. 22, 1013-1022 (1992).
49. + T cell help. J. Exp. Med. 189, 1157-1162 (1999).
50. Nishimura, H., Honjo, T. & Minato, N. Facilitation of beta selection and modification of positive selection in the thymus of PD-1-deficient mice. J. Exp. Med. 191, 891-898 (2000).
51. Blank, C. et al. Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cells. J. Immunol. 171, 4574-4581 (2003).
52. Walunas, T.L. et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405-413 (1994).
53. Lehmann-Grube, F. Lymphocytic Choriomeningitis Virus. Virol. Monogr. 10, 1-173 (1971).
54. Gallimore, A. et al. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187, 1383-1393 (1998).
55. Probst, H.C., Dumrese, T. & van den Broek, M.F. Cutting edge: competition for APC by CTLs of different specificities is not functionally important during induction of antiviral responses. J. Immunol. 168, 5387-5391 (2002).
56. Battegay, M. et al. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J. Virol. Methods 33, 191-198 (1991).